Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches

Area of Science:

• Biochemistry and Medicinal Chemistry
• Computational Drug Discovery
• Pharmacology

Background:

• Protein kinase inhibitor discovery has transitioned from empirical methods to sophisticated structure and data-driven strategies.
• The increasing availability of potent compounds and kinome-wide binding data fuels advancements in optimizing inhibition across multiple targets.
• Drug repurposing and personalized medicine approaches are becoming central to modern drug discovery efforts.

Purpose of the Study:

• To explore the evolution of structure-based protein kinase inhibitor discovery.
• To highlight the role of data-driven approaches and computational tools in optimizing inhibitor properties.
• To discuss the challenges and opportunities in adapting known compounds for new therapeutic uses.

Main Methods:

• Leveraging sequence and structural information for protein kinase target similarity quantification.
• Utilizing cheminformatics and statistical methods to correlate data and predict activity.
• Analyzing experimental data from focused chemical libraries, drug repurposing, and polypharmacological design.

Main Results:

• Data-driven approaches enable optimization of inhibition properties across multiple protein kinase targets.
• Successful examples of drug repurposing and polypharmacological design illustrate the potential of these methods.
• Challenges remain in data type mismatches and precise prediction of ligand binding energies from individual structures.

Conclusions:

• The field is moving towards personalized medicine and niche applications, away from single blockbuster drug models.
• Integrating diverse data types and refining computational methods are crucial for advancing data-driven drug discovery.
• Despite challenges, experimental data increasingly supports focused efforts in inhibitor design and drug repurposing.